Recent Advances in Microtubule Targeting Agents for Cancer Therapy.

Molecules · 2025 · PMC12388312 · PMID 40871468

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In vivo, testing with an MDA-MB-435 xenograft mouse model revealed that treatment with 125 did not demonstrate statistically significant antitumor activity, but showed a trend towards lower tumor volume [ 106 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.